According to FutureWise analysis, the market for Biobetters is expected to register a CAGR of 8.02% from 2025 to 2033. Recombinant protein medications developed alongside existing biopharmaceuticals are known as "biobetters" or "superiors." alternatives. These medications are designed to offer advantages over the original products. While they are not entirely novel drugs, nor are...